Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

MONTALTO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.852
EU - Europa 14.826
AS - Asia 8.878
SA - Sud America 1.728
AF - Africa 320
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 20
Totale 52.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.622
IT - Italia 6.537
SG - Singapore 3.246
CN - Cina 3.139
FI - Finlandia 1.599
BR - Brasile 1.444
UA - Ucraina 1.372
DE - Germania 1.069
RU - Federazione Russa 1.015
HK - Hong Kong 922
IE - Irlanda 684
GB - Regno Unito 575
PL - Polonia 491
VN - Vietnam 426
SE - Svezia 390
FR - Francia 336
IN - India 202
NL - Olanda 167
TR - Turchia 136
RO - Romania 128
BE - Belgio 127
KR - Corea 123
CI - Costa d'Avorio 103
CA - Canada 96
AR - Argentina 93
JP - Giappone 89
MX - Messico 79
AT - Austria 76
BD - Bangladesh 72
IR - Iran 67
ES - Italia 66
UZ - Uzbekistan 66
IQ - Iraq 58
ZA - Sudafrica 55
ID - Indonesia 49
EC - Ecuador 42
MA - Marocco 42
VE - Venezuela 41
AU - Australia 40
EG - Egitto 39
MY - Malesia 32
CO - Colombia 31
GR - Grecia 31
CH - Svizzera 30
PK - Pakistan 26
KE - Kenya 25
LB - Libano 24
PH - Filippine 24
SA - Arabia Saudita 24
AE - Emirati Arabi Uniti 21
CZ - Repubblica Ceca 21
BG - Bulgaria 20
CL - Cile 19
PY - Paraguay 19
AZ - Azerbaigian 18
NP - Nepal 18
DZ - Algeria 17
RS - Serbia 17
IL - Israele 16
LT - Lituania 16
PE - Perù 13
UY - Uruguay 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
KZ - Kazakistan 12
TN - Tunisia 12
EU - Europa 11
NZ - Nuova Zelanda 11
AL - Albania 10
HN - Honduras 9
JM - Giamaica 9
JO - Giordania 9
TW - Taiwan 9
DK - Danimarca 7
GE - Georgia 7
CR - Costa Rica 6
PA - Panama 6
EE - Estonia 5
ET - Etiopia 5
HU - Ungheria 5
KG - Kirghizistan 5
LU - Lussemburgo 5
NO - Norvegia 5
OM - Oman 5
PT - Portogallo 5
SV - El Salvador 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
HR - Croazia 4
PS - Palestinian Territory 4
SN - Senegal 4
BH - Bahrain 3
BY - Bielorussia 3
GH - Ghana 3
GT - Guatemala 3
KH - Cambogia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
Totale 52.633
Salva come PNG Salva come JPEG
Città #
Fairfield 3.540
Ashburn 3.151
Chandler 1.965
Singapore 1.833
Woodbridge 1.730
Houston 1.587
Wilmington 1.554
Seattle 1.356
Cambridge 1.209
Ann Arbor 1.176
Hong Kong 898
Jacksonville 690
Dublin 680
Medford 618
Beijing 536
Des Moines 524
Palermo 504
Nanjing 424
Milan 423
Princeton 394
Altamura 392
Zgierz 392
Moscow 339
Dallas 333
New York 313
Los Angeles 299
Dearborn 286
Rome 280
Lawrence 268
San Diego 235
The Dalles 228
Tulsa 202
Boardman 196
Santa Clara 167
Nanchang 158
Ho Chi Minh City 154
Shenyang 153
Naples 141
Jinan 139
Changsha 138
São Paulo 138
Buffalo 136
Hefei 134
Hebei 133
Brussels 117
Tianjin 110
Abidjan 103
Hanoi 91
Munich 89
London 88
Chicago 87
Columbus 81
Falls Church 79
Ludwigshafen am Rhein 78
Jiaxing 77
Tokyo 72
Nuremberg 71
Seongnam 71
Verona 71
Venice 67
Ningbo 65
Florence 64
Redwood City 60
Guangzhou 59
Saint Petersburg 57
Zhengzhou 57
Frankfurt am Main 56
Bologna 55
San Paolo di Civitate 54
Izmir 51
Helsinki 50
Phoenix 50
Warsaw 50
Hangzhou 49
Council Bluffs 47
Turin 47
Tashkent 43
Brooklyn 42
Rio de Janeiro 40
Denver 39
Johannesburg 39
Taizhou 39
Kumar 38
Bremen 37
Napoli 37
Tehran 37
Belo Horizonte 35
Cagliari 35
Lanzhou 34
Catania 33
Bari 31
Haikou 31
Turku 31
Vienna 31
Düsseldorf 30
Amsterdam 29
Chennai 29
San Mateo 29
Salerno 28
Montreal 27
Totale 33.193
Salva come PNG Salva come JPEG
Nome #
Nodulo epatico ipovascolare: ruolo dell’ecografia nella diagnosi di HCC 4.176
ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES 314
A phenobarbital overdose: a case report 270
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 250
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 243
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 236
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review 234
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 233
Hepatocellular carcinoma: Comparison of two different periods at the same center 228
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 218
Cytochrome P450 2E1 variable number tandem repeat polymorphisms and health risks: A genotype-phenotype study in cancers associated with drinking and/or smoking 217
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 216
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 214
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 214
Serological Pattern of Hepatitis B, C, and HIV Infections Among Immigrants in Sicily: Epidemiological Aspects and Implication on Public Health 211
The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine 210
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 207
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 207
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 207
Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells 206
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 203
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 198
Encefalopatia iponatriemica in peritonite batterica spontanea in soggetto con cirrosi epatica scompensata. 196
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 196
Genetic determined down regulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 195
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 195
A key role for abdominal ultrasound examination in "difficult" diagnoses of celiac disease 194
Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis. 193
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 191
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects 190
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 190
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 188
Food allergy in gastroenterologic diseases: review of literature 187
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 187
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children 186
Associated Factors and Liver Disease Severity for Decreased Bone Mineral Density in HIV Mono- and HIV/HCV Co-infected Patients 186
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 183
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 183
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 182
Solitary necrotic nodule of the liver: different pathological findings express a different histogenesis 181
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 180
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 180
Screening for autoantibodies to tissue transglutaminase reveals a low prevalence of celiac disease in blood donors with cryptogenic hypertransaminasemia 180
Association Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-a, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular Carcinoma 179
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 179
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 178
Evaluation by ultrasound of abdominal lymphadenopathy in chronic hepatitis C 178
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 178
Low-grade fever: how to distinguish organic from non-organic forms. 177
Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection 177
Concomitant inflammatory pseudotumor of the liver and spleen 177
Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. 176
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 176
Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study 176
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 175
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 175
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 175
Serum low density lipoprotein subclasses in asthma 174
The effect of bergamot on dyslipidemia 173
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? 172
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 172
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 170
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 169
Abnormal liver function in brucellosis 167
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 166
Perihepatic limph nodes and anti-viral response in chronic HCV-associated hepatitis 165
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 165
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. 164
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells 164
CYP2E1 VNTR polymorphisms and hepatocarcinoma: a gender-specific correlation 164
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 164
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population 164
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort. 164
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 163
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 162
Sex hormones and risk of liver tumor 162
Assessment of a qualitative serological assay to screen for allergic sensitization in elderly subjects 161
Percutaneous liver biopsy: A safe outpatient procedure? 161
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 161
Basi fisiopatologiche dell'encefalopatia minima del cirrotico 160
Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study 160
Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis 160
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 159
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 159
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 159
Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment 158
Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis 158
Circulating levels of molecular adhesion correlate with stage of renal disease and C-reactive protein in chronic kidney disease 157
Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease 156
Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy. 156
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 156
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 155
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 155
Metformin influences drug sensitivity in pancreatic cancer cells 155
Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment 154
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 154
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 154
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 153
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial 152
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 152
Totale 22.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.110 0 0 0 0 0 241 426 431 560 491 413 548
2021/20224.701 241 919 135 210 174 200 194 301 591 614 274 848
2022/20236.351 641 1.110 100 604 649 923 468 501 654 102 339 260
2023/20244.007 226 519 259 383 333 608 326 268 81 344 218 442
2024/20257.522 253 620 491 790 366 300 487 454 624 743 968 1.426
2025/20268.345 1.542 695 1.220 1.694 2.108 1.086 0 0 0 0 0 0
Totale 54.296